Artelo Biosciences, Inc. Warrant
ARTLW
ARTLW was delisted on the 17th of June, 2024.
5 hedge funds and large institutions have $15K invested in Artelo Biosciences, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
12% less capital invested
Capital invested by funds: $17K → $15K (-$2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$55 |
ARTLW Hedge Fund Activity: Q3 2021 in Review
5 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Artelo Biosciences, Inc. Warrant (ARTLW) for Q3 2021, worth a combined $15K — down 12% from $17K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new ARTLW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $4.01K. The largest seller was UBS Group, cutting an estimated $55.
- 5 institutional investors held Artelo Biosciences, Inc. Warrant (ARTLW) as of Q3 2021, up from 4 in Q2 2021.
- Funds reported $15K of Artelo Biosciences, Inc. Warrant stock for Q3 2021, down 12% quarter-over-quarter.
- 1 fund opened new Artelo Biosciences, Inc. Warrant positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest Artelo Biosciences, Inc. Warrant buyer in Q3 2021 was Susquehanna International Group, an estimated $4.01K added.
- The largest Artelo Biosciences, Inc. Warrant seller in Q3 2021 was UBS Group, an estimated $55 sold.
Based on aggregated 13F filings for Q3 2021.